Key Highlights
- Hosted in Jodhpur, Rajasthan from 30 July to 1 August 2026 over three days.
- Brings together clinicians, researchers, policy makers and patient advocates from over a dozen nations.
- Centers on affordable insulin, continuous glucose monitoring, insulin‑pump therapy and digital health solutions ruas.
- Reinforces India’s emerging leadership in global diabetes education and outreach.
- Post‑summit, the venue tsey to announce the 2027 edition.
Detailed Insights
The International Type 1 Diabetes Summit 2026 will unfold in Jodhpur, Rajasthan, for three days, gathering a constellation of stakeholders: world‑famous endocrinologists, funding bodies such as the Friends of Mewar, Breakthrough T1D, and the William J. Clinton Foundation. Participants will tackle both scientific and societal pillars—including the battle for universal insulin access, the latest CGM technologies, insulin‑pump compatibility, digital health platforms, and psychosocial support infrastructures. The summit’s ambition is to translate dialogue into actionable policy, clinical protocols, and international research collaborations that elevate patient quality of life. India’s pivotal role is underscored further by the summit’s announcement on 23 July 2026 at the Constitution Club in New Delhi, a move that highlights the nation’s commitment to diabetes awareness and global cooperation.
Key Concepts
- Type 1 Diabetes – A lifelong autoimmune condition where pancreatic betaŢ- cells are destroyed, necessitating external insulin.
- Autoimmune Disorder – Inflammation triggered by the immune system attacking the body’s own tissues.
- Continuous Glucose Monitoring (CGM) – Wearable technology that provides real‑time glucose readings to guide therapy.
- Insulin Pump Therapy – A device that delivers insulin continuously, mimicking natural pancreatic activity.
- Digital Health Solutions – Software, apps, and remote monitoring tools to support disease management.
